263 related articles for article (PubMed ID: 8554111)
1. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis.
Pittaluga S; Verhoef G; Criel A; Wlodarska I; Dierlamm J; Mecucci C; Van den Berghe H; De Wolf-Peeters C
Am J Surg Pathol; 1996 Feb; 20(2):211-23. PubMed ID: 8554111
[TBL] [Abstract][Full Text] [Related]
2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
3. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
[TBL] [Abstract][Full Text] [Related]
4. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
5. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
6. Small lymphocytic lymphomas with predominant splenomegaly: a comparison of immunophenotypes with cases of predominant lymphadenopathy.
Hollema H; Visser L; Poppema S
Mod Pathol; 1991 Nov; 4(6):712-7. PubMed ID: 1724085
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
8. Cytology and immunophenotyping of low- and intermediate-grade B-cell non-Hodgkin's lymphomas with a predominant small-cell component: a study of 56 cases.
Chhieng DC; Cohen JM; Cangiarella JF
Diagn Cytopathol; 2001 Feb; 24(2):90-7. PubMed ID: 11169886
[TBL] [Abstract][Full Text] [Related]
9. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
10. Intermediate lymphocytic lymphoma encompassing diffuse and mantle zone pattern variants. A distinct entity among low-grade lymphomas?
Carbone A; Poletti A; Manconi R; Cozzi M; Sulfaro S; Zagonel V; Tirelli U; Volpe R
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):113-21. PubMed ID: 2522045
[TBL] [Abstract][Full Text] [Related]
11. Mantle-cell lymphoma.
De Wolf-Peeters C; Pittaluga S
Ann Oncol; 1994; 5 Suppl 1():35-7. PubMed ID: 8172814
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characteristics of monocytoid B cell lymphoma, mantle zone lymphoma, small lymphocytic lymphoma (or B chronic lymphocytic leukemia), and hairy cell leukemia.
Oka K; Mori N; Yatabe Y
Acta Haematol; 1993; 90(2):84-9. PubMed ID: 8285023
[TBL] [Abstract][Full Text] [Related]
13. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
14. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
15. Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Wu CD; Jackson CL; Medeiros LJ
Am J Clin Pathol; 1996 Mar; 105(3):277-85. PubMed ID: 8602607
[TBL] [Abstract][Full Text] [Related]
16. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma.
Kurtin PJ
Adv Anat Pathol; 1998 Nov; 5(6):376-98. PubMed ID: 10095879
[TBL] [Abstract][Full Text] [Related]
18. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
19. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
[TBL] [Abstract][Full Text] [Related]
20. Splenic lymphoproliferative disorders in human T lymphotropic virus type-I endemic area of japan: clinicopathological, immunohistochemical and genetic analysis of 27 cases.
Kumagawa M; Suzumiya J; Ohshima K; Kanda M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 May; 41(5-6):593-605. PubMed ID: 11378577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
